JPS62263192A - Production of egg yolk lecithin - Google Patents
Production of egg yolk lecithinInfo
- Publication number
- JPS62263192A JPS62263192A JP10478786A JP10478786A JPS62263192A JP S62263192 A JPS62263192 A JP S62263192A JP 10478786 A JP10478786 A JP 10478786A JP 10478786 A JP10478786 A JP 10478786A JP S62263192 A JPS62263192 A JP S62263192A
- Authority
- JP
- Japan
- Prior art keywords
- solvent
- lecithin
- egg yolk
- manufacturing
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 title claims description 9
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 34
- 239000000787 lecithin Substances 0.000 claims abstract description 34
- 229940067606 lecithin Drugs 0.000 claims abstract description 34
- 235000010445 lecithin Nutrition 0.000 claims abstract description 34
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 150000002632 lipids Chemical class 0.000 claims abstract description 25
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 24
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 21
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 21
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000012528 membrane Substances 0.000 claims abstract description 14
- 239000012046 mixed solvent Substances 0.000 claims abstract description 14
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 10
- 150000001298 alcohols Chemical class 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 abstract description 11
- -1 ethanol Chemical compound 0.000 abstract description 2
- 238000005194 fractionation Methods 0.000 abstract description 2
- 239000013557 residual solvent Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000001914 filtration Methods 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- OZXIZRZFGJZWBF-UHFFFAOYSA-N 1,3,5-trimethyl-2-(2,4,6-trimethylphenoxy)benzene Chemical compound CC1=CC(C)=CC(C)=C1OC1=C(C)C=C(C)C=C1C OZXIZRZFGJZWBF-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- SHOJXDKTYKFBRD-UHFFFAOYSA-N mesityl oxide Natural products CC(C)=CC(C)=O SHOJXDKTYKFBRD-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
「産業上の利用分野」
本発明はレシチンを卵黄から抽出製造する方法に関する
。特に医薬品等に用いることのできる高純度のレシチン
を衛生的に高収率で得ることのできる方法に関する。DETAILED DESCRIPTION OF THE INVENTION "Field of Industrial Application" The present invention relates to a method for extracting and producing lecithin from egg yolk. In particular, the present invention relates to a method for hygienically obtaining high-yield lecithin of high purity that can be used in pharmaceuticals and the like.
レシチンはその界面活性性から食品分野、医薬品分野に
利用されており、卵黄レシチンは乳化持性、安全性から
人工血液、リポ乳剤、ビタミンEなど医薬品分野の利用
・開発が行われている。よって安価に安全性の高い卵黄
レシチンの製造方法を確立することはこれらの産業への
寄与は大である。Lecithin is used in the food and pharmaceutical fields due to its surface activity, and egg yolk lecithin is used and developed in the pharmaceutical field, including artificial blood, lipo-emulsions, and vitamin E, due to its emulsification retention and safety. Therefore, establishing a method for producing egg yolk lecithin that is inexpensive and highly safe will greatly contribute to these industries.
「従来の技術」
卵黄レシチンの製造方法はいくつか知られており、特公
昭56−47915、特公昭46−42186特公昭3
7−6259などが挙げられる。特公昭56−4791
5はジメチルエーテルで生卵黄からレシチン、中性脂質
および一部の水を抽出分離し脱溶剤後抽出油分中の水分
含量と調整することによりレシチンと中性脂質を分離す
る方法である。``Prior art'' There are several known methods for producing egg yolk lecithin.
7-6259 and the like. Tokuko Sho 56-4791
Method 5 is a method for separating lecithin and neutral lipids by extracting and separating lecithin, neutral lipids, and some water from raw egg yolk with dimethyl ether, removing the solvent, and adjusting the water content in the extracted oil.
この方法ではレシチンは水と一緒に回収するため、その
後脱水、乾燥をする必要があるが、レシチンの品質に影
響を及ぼすため品温を高くすることができず高コストで
ある凍結乾燥を強いられるなどの欠点を有する。In this method, lecithin is recovered together with water, so it must be dehydrated and dried afterwards, but it is not possible to raise the temperature of the product because it affects the quality of the lecithin, forcing expensive freeze-drying. It has drawbacks such as:
特公昭46−42186は卵黄に半量から倍量の1価ア
ルコールと少量の酸を加えPH3〜6程度にし攪拌した
のち、卵黄の倍量から4倍量の水を加えて遠心分離する
ことによって上層からリン脂質を含まないトリグリセリ
ド・ステリンの層をリン脂質の層とたん白の層に分ける
ことを特徴とする。これは酸やアルコールによってたん
白を変性させることによって脂質とたん白質とを分離さ
せやすい形とし、通常植物油の脱ガム(リン脂質分の除
去)で知られるようにリン脂質が、水の存在下でトリグ
リセリドなどの中性脂質に溶解しないことを利用して、
水を加えトリグリセリドとの分離を、更には比重差から
たん白との分離を行うものである。Japanese Patent Publication No. 46-42186 involves adding half to twice the amount of monohydric alcohol and a small amount of acid to egg yolk, stirring to bring the pH to about 3 to 6, and then adding twice to four times the amount of water to the egg yolk and centrifuging to remove the upper layer. It is characterized by separating the triglyceride/sterin layer, which does not contain phospholipids, into a phospholipid layer and a protein layer. This process denatures protein with acid or alcohol, making it easier to separate lipids and proteins.As is known from degumming (removal of phospholipid content) from vegetable oils, phospholipids are removed in the presence of water. Taking advantage of the fact that it does not dissolve in neutral lipids such as triglycerides,
Water is added to separate it from triglycerides, and it is further separated from proteins based on the difference in specific gravity.
特公昭37−6259は酸を添加した無水アルコール類
で水分含iを37〜29%に半乾燥調整した卵黄を浸漬
処理濾過したのち、油脂溶剤を使用して抽出卵黄油を得
る方法である。この方法は半乾燥など前処理工程が必要
であり、酸の除去。Japanese Patent Publication No. 37-6259 discloses a method for obtaining extracted egg yolk oil by soaking and filtering egg yolks which have been semi-dried to a moisture content of 37 to 29% with acid-added absolute alcohols, and then using an oil-fat solvent. This method requires pretreatment steps such as semi-drying and acid removal.
濾過などの工程が複雑であると共に得られる卵黄油は本
発明者らが期待する高純度のレシチンと異なり中性脂質
を含むものである。The steps such as filtration are complicated, and the obtained egg yolk oil contains neutral lipids, unlike the high-purity lecithin expected by the present inventors.
レシチンは通常アセトンに不溶であるが、中性脂質はア
セトンに可溶であるため、この特性を利用してレシチ、
ンを精製する方法も知られているが、これらの方法では
脱アセトンが容易ではなく特有の臭いを有するメシチル
オキシドが残留するなどの欠点がある。Lecithin is normally insoluble in acetone, but neutral lipids are soluble in acetone, so lecithin,
Methods for purifying methane are also known, but these methods have the disadvantage that deacetonization is not easy and mesityl oxide, which has a characteristic odor, remains.
以上の如く、これまで知られている方法は高コストであ
ったり、工程が複雑であったり、特有の有臭の成分を含
むなど、まだ改善される余地がある。As described above, the methods known so far are high in cost, have complicated steps, and contain components with unique odors, so there is still room for improvement.
「発明が解決しようとする問題点」
本発明の目的は卵黄からレシチンを含む脂質を抽出して
該脂質からレシチンを製造するにあたり、食品製造に一
般的に用いられる安全な溶剤を使用することができ、衛
生的に安全で高純度のレシチンを高収率で得ることので
きる方法を提供することにある。"Problems to be Solved by the Invention" The purpose of the present invention is to extract lipids containing lecithin from egg yolks and to produce lecithin from the lipids using safe solvents commonly used in food production. The object of the present invention is to provide a method capable of obtaining hygienically safe and highly purified lecithin at a high yield.
卵黄は水分約50%、たん白質約15%、脂質約35%
からなり、中性脂質がレシチン、コレステロール、たん
白によって乳化された系となっている。この乳化は非常
に安定であるために単純にヘキサン等の非極性溶剤によ
って抽出操作を行なっても非常に抽出率が低く、特に極
性脂質であるリン脂質は抽出されにくい。Egg yolk is approximately 50% water, 15% protein, and 35% fat.
It is a system in which neutral lipids are emulsified with lecithin, cholesterol, and protein. Since this emulsion is very stable, even if an extraction operation is performed simply with a non-polar solvent such as hexane, the extraction rate is very low, and in particular, phospholipids, which are polar lipids, are difficult to extract.
本発明者らは乳化がレシチン、コレステロール・たん白
による作用であることに注目し、好ましくは凍結等によ
りたん白を変性させ、次いでアルコール類と非極性溶剤
の混合溶剤を用いることによってこの乳化系を破壊し効
率よく脂質を抽出し、次いでこの抽出工程からレシチン
と中性油を筒便に分別して、レシチンを高収率で製造で
きる方法を見い出し、本発明を完成するに至った。The present inventors focused on the fact that emulsification is an effect of lecithin, cholesterol, and protein, and preferably denatured the protein by freezing, etc., and then used a mixed solvent of alcohols and non-polar solvents to create an emulsified system. The present inventors have discovered a method for producing lecithin at a high yield by destroying it and efficiently extracting lipids, and then separating lecithin and neutral oil from this extraction process into fecal matter, thereby completing the present invention.
「問題点を解決するための手段」
すなわち、本発明は卵黄中の脂質をアルコール類および
非極性溶剤からなる混合溶剤で抽出し、該混合溶剤層に
水を添加し、水−アルコール類層を限外濾過膜で処理し
てレシチンを得ることを特徴とする卵黄レシチンの製造
方法である。"Means for Solving the Problems" That is, the present invention extracts lipids in egg yolk with a mixed solvent consisting of alcohols and non-polar solvents, adds water to the mixed solvent layer, and extracts the water-alcohol layer. This is a method for producing egg yolk lecithin, which is characterized in that lecithin is obtained by treatment with an ultrafiltration membrane.
以下、本発明の詳細な説明する。The present invention will be explained in detail below.
本発明においては、卵黄からレシチンを抽出製造するに
あたり、まずアルコール類、非極性溶剤から成る混合溶
剤を卵黄に加えて攪拌後、固液分離することによってレ
シチンを含む脂質を抽出した溶剤を回収する。In the present invention, when extracting and manufacturing lecithin from egg yolk, first, a mixed solvent consisting of alcohols and a non-polar solvent is added to the egg yolk, and after stirring, solid-liquid separation is performed to recover the solvent from which lipids containing lecithin are extracted. .
この場合、好ましくは卵黄を凍結することによって予め
卵黄たん白質を変性させておくことにより抽出を効率的
に行うことができる。In this case, the extraction can be carried out efficiently by denaturing the egg yolk protein in advance, preferably by freezing the egg yolk.
卵黄は産業上利用される場合、衛生上、保管上凍結して
利用されることが多いが、この際は食塩など塩類や砂糖
など*iを添加することによってたん白質の変性を少な
くして供給使用される。When egg yolks are used industrially, they are often frozen for hygiene and storage reasons, but in this case, salts such as table salt, sugar, etc.*i are added to reduce protein denaturation. used.
本発明では卵黄をそのまま凍結することによって積極的
にたん白質を変性させその後の抽出率が上がることを見
い出した。凍結は衛生的であれば瞬間凍結をする必要が
なく通常冷凍配送される温度に保管されれば良い。In the present invention, we have discovered that by freezing egg yolks as they are, proteins are actively denatured and the subsequent extraction rate is increased. If freezing is sanitary, there is no need to flash freeze the food, and it is sufficient to store it at the temperature at which it is normally shipped frozen.
本発明に用いられるアルコール類としては、メタノール
、エタノール、プロパツール等を用いることができるが
、食品衛生上の観点からエタノールを用いることが好ま
しい、非極性溶剤としてはベンゼン、ヘキサン等が使用
できるが、現在も食用油抽出などに利用されているn−
ヘキサンを用いることが望ましい。混合溶剤の使用量は
、抽出効率の点から好ましくは卵黄1〜5倍の容量であ
る。As the alcohol used in the present invention, methanol, ethanol, propatool, etc. can be used, but from the viewpoint of food hygiene, it is preferable to use ethanol.As the non-polar solvent, benzene, hexane, etc. can be used. , n-, which is still used for edible oil extraction, etc.
Preferably hexane is used. The amount of mixed solvent used is preferably 1 to 5 times the volume of egg yolk in terms of extraction efficiency.
本発明に用いられる混合溶剤中のアルコール類と非極性
溶剤の混合比率はアルコール順/非極性溶剤−5015
0〜10/90が好ましく更に好ましくは25/75〜
15/85である。第1表に示すようにアルコール類の
比率が多くなると抽出脂質中のリン脂質含量は高くなる
が、総脂質抽出率が低くなり、好ましくない、またアル
コール類の比率が低いと総脂質抽出率も低いと同時にリ
ン脂質含量も低くなり好ましくない、これらの結果から
上記の混合比率が好ましい。The mixing ratio of alcohols and non-polar solvents in the mixed solvent used in the present invention is in the order of alcohol/non-polar solvent-5015
0 to 10/90 is preferable, more preferably 25/75 to
It is 15/85. As shown in Table 1, when the ratio of alcohols increases, the phospholipid content in the extracted lipids increases, but the total lipid extraction rate decreases, which is undesirable. At the same time, the phospholipid content also becomes low, which is undesirable.From these results, the above mixing ratio is preferable.
第1表 抽出率
注)凍結卵黄1000 gに対し溶剤2000mjlを
加えて常温でホモミキサーを用いて撹拌後、遠心分離し
て得られる溶剤層中の脂質分について分析固液分離した
溶剤相にはレシチン、中性脂質などが抽出されるが、次
工程で限外濾過処理するにあたって、アルコール類の除
去を行なわねばならない、このため分離された溶剤相中
の非極性溶剤に対して0.01〜0.5部の水、好まし
くは0.05〜0.3部の水を加えることによってアル
コール類は水と共に非極性溶媒から分離除去される。Table 1 Extraction rate Note: Add 2000 mjl of solvent to 1000 g of frozen egg yolk, stir at room temperature using a homomixer, centrifuge, and analyze the lipid content in the solvent layer obtained. Lecithin, neutral lipids, etc. are extracted, but alcohols must be removed during the ultrafiltration process in the next step. By adding 0.5 parts of water, preferably 0.05 to 0.3 parts of water, the alcohols are separated off from the non-polar solvent together with the water.
こうして分離したアルコール類水層と非極性溶媒層はデ
カンチーシランなどにより簡単に分離することができる
。The alcohol aqueous layer and the nonpolar solvent layer thus separated can be easily separated using decanethisilane or the like.
この過程で極性溶媒中にレシチンが若干溶解するが、上
記範囲内の水添加量であればその量は無視できる程度で
工業生産上無視できる程度であった。During this process, lecithin was slightly dissolved in the polar solvent, but if the amount of water added was within the above range, the amount was negligible and could be ignored in industrial production.
上記水に塩類を加えて検討した結果、1価の金属塩例え
ば塩化ナトリウム、塩化カリウムを用いることによって
更に水層へのレシチンの分配は低くなり歩留りも向上す
ることが解かった。但しカルシウムやマグネシウムなど
2価の金属塩を用いるとレシチンと反応して不溶物を形
成し歩留りが低かった。As a result of an investigation of adding salts to the water, it was found that by using monovalent metal salts such as sodium chloride and potassium chloride, the distribution of lecithin to the aqueous layer was further reduced and the yield was improved. However, when divalent metal salts such as calcium and magnesium were used, they reacted with lecithin to form insoluble matter, resulting in a low yield.
その後得られる非極性溶剤層を耐溶剤性のある限外濾過
膜を通すことによってレシチン分を中性脂質画分に分画
し、高純度のレシチンを得る。Thereafter, the resulting non-polar solvent layer is passed through a solvent-resistant ultrafiltration membrane to fractionate the lecithin component into a neutral lipid fraction to obtain highly pure lecithin.
限外濾過膜はレシチンの会合物と中性脂質が分画できる
分画分子15000以上であれば良く、純度を高めるた
めに同じ非極性溶剤を用いて定容濾過回分濾過を繰り返
えすこともできる。The ultrafiltration membrane should have a molecular weight fraction of 15,000 or more that can separate lecithin aggregates and neutral lipids, and constant volume filtration and batch filtration may be repeated using the same non-polar solvent to increase purity. can.
このような限外濾過膜としては、ダイセル化学工業■製
のDOS−40(円管型モジュール、膜素材:ポリエー
テルサルホン、分画分子量: 40000)、ロミコン
社製PM−10,30,50および100中空糸モジユ
ール、膜素材:ポリスルホン、分画分子量は、それぞれ
、5000.10000,30000.50000およ
び100000) 、三井石油化学工業■製IRIS−
3038(平板型モジュール、膜素材:ポリアクリロニ
トリル共重合体、分画分子量: 15000〜2000
0およびMPS−3400(平板型モジエール、膜素材
:ポリスルホン、分画分子11 : 30000〜40
000)などがある。Examples of such ultrafiltration membranes include DOS-40 (cylindrical module, membrane material: polyethersulfone, molecular weight cutoff: 40,000) manufactured by Daicel Chemical Industries, Ltd., and PM-10, 30, 50 manufactured by Romicon. and 100 hollow fiber module, membrane material: polysulfone, molecular weight cut off: 5000.10000, 30000.50000 and 100000, respectively), IRIS- manufactured by Mitsui Petrochemical Corporation ■
3038 (flat plate module, membrane material: polyacrylonitrile copolymer, molecular weight cutoff: 15,000-2,000
0 and MPS-3400 (flat plate model, membrane material: polysulfone, fractionated molecules 11: 30,000-40
000).
「実施例」
実施例1
凍結卵黄1000 gにヘキサン1000m l 、エ
タノール1000m lの混合溶剤を加え、ホモミキサ
ーで5分間攪拌したのち、3000rpm 5分間遠心
分離して溶剤11820m/を得た。この溶剤層に水3
00m1を加えて混合静置したのち、デカンテーション
を行ってヘキサンiJ980mlを得た。ヘキサン層中
の脂質含量は25.8%であった。これをダイセル化学
工業−社製限外濾過膜D[1S−40(分画分子量40
000)でヘキサン3000mA!を用いて定容濾過を
行い、90%純度の卵黄レシチン82gを得た。"Example" Example 1 A mixed solvent of 1000 ml of hexane and 1000 ml of ethanol was added to 1000 g of frozen egg yolk, stirred for 5 minutes using a homomixer, and then centrifuged at 3000 rpm for 5 minutes to obtain 11,820 m/ml of a solvent. Water 3 in this solvent layer
After adding 00 ml of the mixture and allowing it to stand still, decantation was performed to obtain 980 ml of hexane iJ. The lipid content in the hexane layer was 25.8%. This ultrafiltration membrane D [1S-40 (molecular weight cut off 40) manufactured by Daicel Chemical Industries, Ltd.
000) and hexane 3000mA! Volumetric filtration was performed using a filtration solution to obtain 82 g of egg yolk lecithin with a purity of 90%.
実施例2
凍結卵黄1000 gにヘキサン1600m l! 、
エタノール400mm!の混合溶剤を加えホモミキサー
で5分間攪拌したのち、3000rpm 5分間遠心分
離して溶剤1t1960mlの溶剤層を得た。こお溶剤
層に3%食塩水200mjを加えて混合静置したのち、
デカンテーションを行なってヘキサン層1620m I
lを得た。ヘキサン中の脂質含量は20.8%であった
。Example 2 1000 g of frozen egg yolk and 1600 ml of hexane! ,
Ethanol 400mm! After adding a mixed solvent and stirring for 5 minutes using a homomixer, centrifugation was performed at 3000 rpm for 5 minutes to obtain a solvent layer containing 1 ton of solvent and 1960 ml of solvent. After adding 200mj of 3% saline solution to the solvent layer and leaving it to stand,
Perform decantation to obtain a hexane layer of 1620 m I
I got l. The lipid content in hexane was 20.8%.
これを三井石油化学工業■製限外濾過膜、MPS −3
400(分画分子量30000〜40000)で300
0m lを用いて定容濾過を行ない95%純度卵黄レシ
チン108gを得た。This is an ultrafiltration membrane manufactured by Mitsui Petrochemical Industries, Ltd., MPS-3.
400 (molecular weight cut off 30,000-40,000)
Volumetric filtration was performed using 0ml to obtain 108g of 95% pure egg yolk lecithin.
「発明の効果」
以上から明らかな如く、本発明によれば医薬品に用いる
ことのできる高純度の卵黄レシチンを簡便、高収率且つ
衛生的に安全に製造することができる0本発明によって
得られるレシチンはアセトン分別などによって得られる
ものとは異なり非常に風味の良いものであり、香粧品、
食品等に乳化剤、界面活性剤として利用価値が高いもの
である。"Effects of the Invention" As is clear from the above, according to the present invention, high-purity egg yolk lecithin that can be used in pharmaceuticals can be produced simply, in high yield, and hygienically and safely. Lecithin has a very good flavor, unlike that obtained by fractionation with acetone, and is used in cosmetics, cosmetics, etc.
It has high utility value as an emulsifier and surfactant in foods, etc.
Claims (10)
らなる混合溶剤で抽出し、該混合溶剤層に水を添加し、
水−アルコール類層を分別し、得られた非極性溶剤層を
限外濾過膜で処理してレシチンを得ることを特徴とする
卵黄レシチンの製造方法。(1) Extract the lipids in the egg yolk with a mixed solvent consisting of alcohols and non-polar solvents, add water to the mixed solvent layer,
A method for producing egg yolk lecithin, which comprises separating a water-alcohol layer and treating the obtained non-polar solvent layer with an ultrafiltration membrane to obtain lecithin.
第1項記載の製造方法。(2) The manufacturing method according to claim 1, wherein the alcohol is ethanol.
第1項記載の製造方法。(3) The manufacturing method according to claim 1, wherein the nonpolar solvent is n-hexane.
求の範囲第1項記載の製造方法。(4) The manufacturing method according to claim 1, wherein extraction is performed with a mixed solvent of 1 to 5 times the volume of egg yolk.
がアルコール類/非極性溶剤=50/50〜10/90
である特許請求の範囲第1項記載の製造方法。(5) The mixing ratio of alcohol and non-polar solvent in the mixed solvent is alcohol/non-polar solvent = 50/50 to 10/90
The manufacturing method according to claim 1.
いる非極性溶剤1部に対して0.01〜0.5倍の範囲
である特許請求の範囲第1項に記載の製造方法。(6) The production according to claim 1, wherein the amount of water added to the solvent phase obtained by solid-liquid separation is in the range of 0.01 to 0.5 times based on 1 part of the non-polar solvent used. Method.
許請求の範囲第1項記載の製造方法。(7) The manufacturing method according to claim 1, wherein the aqueous phase added to the solvent phase contains a monovalent metal salt.
範囲第7項記載の製造方法。(8) The manufacturing method according to claim 7, wherein the monovalent metal salt is sodium chloride.
上である特許請求の範囲第1項記載の製造方法。(9) The manufacturing method according to claim 1, wherein the solvent-resistant ultrafiltration membrane has a molecular weight cutoff of 5,000 or more.
載の製造方法。(10) The manufacturing method according to claim 1, wherein the egg yolk is frozen egg yolk.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10478786A JPS62263192A (en) | 1986-05-09 | 1986-05-09 | Production of egg yolk lecithin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10478786A JPS62263192A (en) | 1986-05-09 | 1986-05-09 | Production of egg yolk lecithin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62263192A true JPS62263192A (en) | 1987-11-16 |
JPH0560839B2 JPH0560839B2 (en) | 1993-09-03 |
Family
ID=14390177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10478786A Granted JPS62263192A (en) | 1986-05-09 | 1986-05-09 | Production of egg yolk lecithin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62263192A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003946A1 (en) * | 1989-09-21 | 1991-04-04 | Canadian Egg Marketing Agency | Extraction of fresh liquid egg yolk |
WO2003056933A3 (en) * | 2002-01-09 | 2003-10-23 | Oladur Ltd | A process for the production of soybean sugars and the product produced thereof |
KR100446833B1 (en) * | 2002-02-05 | 2004-09-04 | 강성식 | Method of Producing Egg Yolk Lecithin |
WO2016190748A1 (en) | 2015-05-27 | 2016-12-01 | Rimfrost As | A flowable concentrated phospholipid krill oil composition |
CN107459547A (en) * | 2017-07-13 | 2017-12-12 | 浙江省农业科学院 | The coproduction separation method of various bioactivators in yolk |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5647915A (en) * | 1979-09-27 | 1981-04-30 | Hitachi Metals Ltd | Manufacture of magnetic head |
JPS5763398A (en) * | 1980-10-03 | 1982-04-16 | Nisshin Oil Mills Ltd | Treatment of oil and fat |
JPS5829712A (en) * | 1981-08-13 | 1983-02-22 | Takeo Haneda | Extraction and separation of lipid of sea snake |
JPS60163888A (en) * | 1984-02-03 | 1985-08-26 | Pola Chem Ind Inc | Production of lipid component |
-
1986
- 1986-05-09 JP JP10478786A patent/JPS62263192A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5647915A (en) * | 1979-09-27 | 1981-04-30 | Hitachi Metals Ltd | Manufacture of magnetic head |
JPS5763398A (en) * | 1980-10-03 | 1982-04-16 | Nisshin Oil Mills Ltd | Treatment of oil and fat |
JPS5829712A (en) * | 1981-08-13 | 1983-02-22 | Takeo Haneda | Extraction and separation of lipid of sea snake |
JPS60163888A (en) * | 1984-02-03 | 1985-08-26 | Pola Chem Ind Inc | Production of lipid component |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003946A1 (en) * | 1989-09-21 | 1991-04-04 | Canadian Egg Marketing Agency | Extraction of fresh liquid egg yolk |
WO2003056933A3 (en) * | 2002-01-09 | 2003-10-23 | Oladur Ltd | A process for the production of soybean sugars and the product produced thereof |
US6913771B2 (en) | 2002-01-09 | 2005-07-05 | Oladur, Ltd | Process for the production of soybean sugars and the product produced thereof |
KR100446833B1 (en) * | 2002-02-05 | 2004-09-04 | 강성식 | Method of Producing Egg Yolk Lecithin |
WO2016190748A1 (en) | 2015-05-27 | 2016-12-01 | Rimfrost As | A flowable concentrated phospholipid krill oil composition |
US10328105B2 (en) | 2015-05-27 | 2019-06-25 | Rimfrost Technologies As | Flowable concentrated phospholipid krill oil composition |
US10525087B2 (en) | 2015-05-27 | 2020-01-07 | Rimfrost Technologies As | Flowable concentrated phospholipid krill oil composition |
CN107459547A (en) * | 2017-07-13 | 2017-12-12 | 浙江省农业科学院 | The coproduction separation method of various bioactivators in yolk |
Also Published As
Publication number | Publication date |
---|---|
JPH0560839B2 (en) | 1993-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5461750B2 (en) | Method for fractionating natural substances containing oil and polar lipids | |
AU2012242355B2 (en) | A process for the isolation of a phospholipid | |
JP5539714B2 (en) | Extraction of highly unsaturated lipids with liquid dimethyl ether | |
JP2977286B2 (en) | Oilseed protein extraction method | |
JP2772213B2 (en) | How to make Zein | |
RU2010111784A (en) | NEW METHOD FOR MAKING KRYLIE FLOUR | |
US7550616B2 (en) | Method for the fractionation of oil and polar lipid-containing native raw materials | |
NO813336L (en) | SEPARATION PROCESS. | |
JP2805522B2 (en) | Method for fractionating and purifying phospholipid fraction derived from milk or dairy products | |
JPS62263192A (en) | Production of egg yolk lecithin | |
JPH0320397A (en) | Highly fresh fish oil containing fish phospholipid and its preparation | |
KR100446833B1 (en) | Method of Producing Egg Yolk Lecithin | |
JP3655435B2 (en) | Method for producing egg yolk lecithin | |
SU1701737A1 (en) | Method of yolk butter preparation | |
EP2168438A1 (en) | Composition richly containing polar lipid and method of manufacturing the same | |
JPH0726287A (en) | Production of yolk lipid | |
AU2013257434B2 (en) | Extraction of highly unsaturated lipids with liquid dimethyl ether | |
WO2010026229A1 (en) | Composition richly containing polar lipid and method of manufacturing the same | |
JPH04266892A (en) | Production of phosphatidic acid compounds | |
EP2163160A1 (en) | Composition richly containing polar lipid and method of manufacturing the same |